RU99107658A - Применение белков в качестве агентов против аутоиммунных заболеваний - Google Patents
Применение белков в качестве агентов против аутоиммунных заболеванийInfo
- Publication number
- RU99107658A RU99107658A RU99107658/14A RU99107658A RU99107658A RU 99107658 A RU99107658 A RU 99107658A RU 99107658/14 A RU99107658/14 A RU 99107658/14A RU 99107658 A RU99107658 A RU 99107658A RU 99107658 A RU99107658 A RU 99107658A
- Authority
- RU
- Russia
- Prior art keywords
- proteins
- use according
- preparation
- drugs
- prevention
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims 6
- 108090000623 proteins and genes Proteins 0.000 title claims 6
- 206010003816 Autoimmune disease Diseases 0.000 title claims 2
- 239000003814 drug Substances 0.000 claims 5
- 229940079593 drugs Drugs 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N Perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Images
Claims (8)
1. Применение белков, выделенных с помощью хлорной кислоты из печени млекопитающего для приготовления лекарственных средств, эффективных против аутоиммунных заболеваний.
2. Применение по п.1, где белок имеет, приведенную в графической части последовательность.
3. Применение по п.1, где выделенные белки гомологичны, по крайней мере, на 80% белку по п.2.
4. Фармацевтическая композиция, содержащая в качестве активного ингредиента белки по пп.1-3 в смеси с подходящими наполнителями.
5. Применение по п.1 для приготовления лекарственных препаратов для предотвращения и лечения атеросклероза в результате трансплантации.
6. Применение по п.1 для приготовления лекарственных препаратов для предотвращения и лечения артритов.
7. Применение по п.1 для приготовления лекарственных препаратов для предотвращения и лечения множественного склероза.
8. Применение по п.1 для приготовления лекарственных препаратов для предотвращения и лечения диабета.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI96A001920 | 1996-09-18 | ||
ITMI961921 IT1284555B1 (it) | 1996-09-18 | 1996-09-18 | Uso di proteine come agenti antidiabetici |
ITMI96A001922 | 1996-09-18 | ||
ITMI961919 IT1284553B1 (it) | 1996-09-18 | 1996-09-18 | Uso di proteine come agenti antiartritici |
ITMI96A001919 | 1996-09-18 | ||
ITMI96A001921 | 1996-09-18 | ||
ITMI961922 IT1284556B1 (it) | 1996-09-18 | 1996-09-18 | Uso di proteine come agenti contro la sclerosi multipla |
ITMI961920 IT1284554B1 (it) | 1996-09-18 | 1996-09-18 | Uso di proteine come agenti antiaterosclerotici |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99107658A true RU99107658A (ru) | 2001-02-20 |
RU2196606C2 RU2196606C2 (ru) | 2003-01-20 |
Family
ID=27453037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99107658/14A RU2196606C2 (ru) | 1996-09-18 | 1997-09-17 | Применение белков в качестве агентов против аутоиммунных заболеваний |
Country Status (22)
Country | Link |
---|---|
US (2) | US6468536B1 (ru) |
EP (1) | EP0928197B1 (ru) |
JP (1) | JP2001501925A (ru) |
KR (1) | KR20000036207A (ru) |
CN (1) | CN1151838C (ru) |
AR (1) | AR009952A1 (ru) |
AT (1) | ATE233569T1 (ru) |
AU (1) | AU723669B2 (ru) |
BR (1) | BR9711499A (ru) |
CA (1) | CA2266346A1 (ru) |
CZ (1) | CZ293926B6 (ru) |
DE (1) | DE69719525T2 (ru) |
DK (1) | DK0928197T3 (ru) |
ES (1) | ES2192669T3 (ru) |
IL (1) | IL129024A0 (ru) |
NO (1) | NO991175D0 (ru) |
NZ (1) | NZ334714A (ru) |
PL (1) | PL188746B1 (ru) |
PT (1) | PT928197E (ru) |
RU (1) | RU2196606C2 (ru) |
TR (1) | TR199900596T2 (ru) |
WO (1) | WO1998011909A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3521382B2 (ja) | 1997-02-27 | 2004-04-19 | 日本たばこ産業株式会社 | 細胞間接着及びシグナル伝達を媒介する細胞表面分子 |
US7112655B1 (en) | 1997-02-27 | 2006-09-26 | Japan Tobacco, Inc. | JTT-1 protein and methods of inhibiting lymphocyte activation |
IT1290828B1 (it) | 1997-03-25 | 1998-12-11 | Zetesis Spa | Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche |
JP4210454B2 (ja) | 2001-03-27 | 2009-01-21 | 日本たばこ産業株式会社 | 炎症性腸疾患治療剤 |
JP3871503B2 (ja) | 1999-08-30 | 2007-01-24 | 日本たばこ産業株式会社 | 免疫性疾患治療剤 |
JP3597140B2 (ja) | 2000-05-18 | 2004-12-02 | 日本たばこ産業株式会社 | 副刺激伝達分子ailimに対するヒトモノクローナル抗体及びその医薬用途 |
AU2001278436A1 (en) | 2000-06-08 | 2001-12-17 | Rakepoll Holding B.V. | A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
JP4212278B2 (ja) | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
ITMI20010762A1 (it) * | 2001-04-10 | 2002-10-10 | Zetesis Spa | Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico |
ITMI20010761A1 (it) * | 2001-04-10 | 2002-10-10 | Zetesis Spa | Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva |
JP2007517808A (ja) * | 2004-01-16 | 2007-07-05 | キュビオ リミテッド | Toll様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン10調節 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024247A (en) * | 1971-12-27 | 1977-05-17 | Palolab Pharmaceuticals Corporation | Composition and method of using a protein mixture derived from liver |
IT1244879B (it) | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
FR2688227A1 (fr) * | 1992-03-04 | 1993-09-10 | Inst Nat Sante Rech Med | Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques. |
IT1270618B (it) | 1994-07-14 | 1997-05-07 | Zetesis Spa | Proteine ad attivita' antitumorale |
-
1997
- 1997-09-17 JP JP10514285A patent/JP2001501925A/ja not_active Ceased
- 1997-09-17 AT AT97910295T patent/ATE233569T1/de not_active IP Right Cessation
- 1997-09-17 RU RU99107658/14A patent/RU2196606C2/ru not_active IP Right Cessation
- 1997-09-17 TR TR1999/00596T patent/TR199900596T2/xx unknown
- 1997-09-17 KR KR1019997002267A patent/KR20000036207A/ko not_active Application Discontinuation
- 1997-09-17 DK DK97910295T patent/DK0928197T3/da active
- 1997-09-17 PT PT97910295T patent/PT928197E/pt unknown
- 1997-09-17 CZ CZ1999915A patent/CZ293926B6/cs not_active IP Right Cessation
- 1997-09-17 AR ARP970104244A patent/AR009952A1/es unknown
- 1997-09-17 CN CNB971980128A patent/CN1151838C/zh not_active Expired - Fee Related
- 1997-09-17 IL IL12902497A patent/IL129024A0/xx unknown
- 1997-09-17 BR BR9711499A patent/BR9711499A/pt not_active IP Right Cessation
- 1997-09-17 DE DE69719525T patent/DE69719525T2/de not_active Expired - Fee Related
- 1997-09-17 WO PCT/EP1997/005079 patent/WO1998011909A1/en not_active Application Discontinuation
- 1997-09-17 EP EP97910295A patent/EP0928197B1/en not_active Expired - Lifetime
- 1997-09-17 NZ NZ334714A patent/NZ334714A/xx unknown
- 1997-09-17 ES ES97910295T patent/ES2192669T3/es not_active Expired - Lifetime
- 1997-09-17 US US09/269,019 patent/US6468536B1/en not_active Expired - Fee Related
- 1997-09-17 AU AU47747/97A patent/AU723669B2/en not_active Ceased
- 1997-09-17 CA CA002266346A patent/CA2266346A1/en not_active Abandoned
-
1999
- 1999-03-10 NO NO991175A patent/NO991175D0/no not_active Application Discontinuation
- 1999-03-17 PL PL97332282A patent/PL188746B1/pl not_active IP Right Cessation
-
2002
- 2002-09-03 US US10/232,712 patent/US20030108558A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0735893T3 (da) | PAN DR-bindende peptider til styrkelse af immunsvaret | |
CA2346438A1 (en) | Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases | |
CA2153584A1 (en) | Cytokine restraining agents | |
MX163955B (es) | Composicion farmaceutica de dihidrocodeina e ibuprofen | |
EP1025840A3 (en) | Oral drug compositions and methods | |
IT1219853B (it) | Fenil carbammato farmacologicamente attivo,suo procedimento di preparazione e composizione farmaceutica che lo contiene | |
RU94033520A (ru) | Впрыскиваемый лецитиновый гель | |
ID17863A (id) | Komposisi-komposisi farmasi yang terdiri dari siklosporin | |
RU99107658A (ru) | Применение белков в качестве агентов против аутоиммунных заболеваний | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
DK184890A (da) | Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme | |
WO1999060013A3 (en) | Il-6 antagonist peptides | |
CA1188218A (en) | PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS | |
CA2112907A1 (en) | Peptide which abrogates tnf and/or lps toxicity | |
IT1299583B1 (it) | Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica | |
IL84484A0 (en) | T-cell suppressor protein in pure form,its preparation by recombinant methods and pharmaceutical compositions containing it | |
IT1224574B (it) | Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono | |
WO1991003226A3 (en) | Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same | |
FR2719593B1 (fr) | Nouveaux polypeptides biologiquement actifs, leur préparation et composition pharmaceutique les contenant. | |
IE831399L (en) | Pharmaceutical composition containing meptazinol and¹ibuprofen. | |
IT1284556B1 (it) | Uso di proteine come agenti contro la sclerosi multipla | |
IT1284553B1 (it) | Uso di proteine come agenti antiartritici | |
IT1284555B1 (it) | Uso di proteine come agenti antidiabetici | |
IT1284554B1 (it) | Uso di proteine come agenti antiaterosclerotici | |
RU99107378A (ru) | Применение белков в качестве антиретровирусных агентов |